Mayank Mamtani

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Mayank Mamtani works at B. RILEY and is covering the the Healthcare sector with 365 price targets and ratings documented since 2018 spanning on 31 stocks. Previously, Mayank Mamtani worked at B. RILEY.

Mayank Mamtani's average stock forecast success ratio is 28.54% with an average time for price targets to be met of 125.32 days.

Most recent stock forecast was given on ICPT, Intercept Pharmaceuticals, Inc at 30-May-2023.

Wall Street Analyst Mayank Mamtani

Analyst best performing recommendations are on VXRT.
The best stock recommendation documented was for NVAX (NOVAVAX, INC) at 5/18/2020. The price target of $53 was fulfilled within 2 days with a profit of $3.96 (6.95%) receiving and performance score of 34.76.

Average potential price target upside

Currently, out of the existing stock ratings of Mayank Mamtani - 2 which are a Buy (100%)

ACST ALNA ALT ARCT ARWR BIVI DRNA ELOX FREQ GANX ICPT MDGL NGM NVAX SAVA SEEL TFFP TGTX VXRT HTBX MBIO SPPI ABUS CBAY INMB AGEN XFOR CGTX GLMD NHWK VKTX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

2.5

$1.97 (371.70%)

3 months 24 days ago

0/1 (0%)

$1.86 (290.63%)

Buy

5

$4.47 (843.40%)

1 years 3 months 24 days ago

0/3 (0%)

$17.13 (296.23%)

Hold

16

2 years 9 months 8 days ago

0/4 (0%)

$28.54 (231.28%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership